primary or secondary prevention of cardiovascular events
Showing 1 - 25 of >10,000
Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)
Not yet recruiting
- Primary Prevention of Atherosclerotic Cardiovascular Disease
- Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
- Placebo in 1.5ml
- (no location specified)
Feb 13, 2023
Diabetes, Type 2, PreDiabetes, Metabolic Syndrome Trial (The Cleerly CAD Staging System)
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- The Cleerly CAD Staging System
- (no location specified)
Oct 31, 2023
Cardiovascular Primary Prevention Strategy Trial in Murray (Coronary Artery Calcium Screening and Statin Treatment, Standard
Recruiting
- Cardiovascular Primary Prevention Strategy
- Coronary Artery Calcium Screening and Statin Treatment
- Standard Treatment
-
Murray, UtahIntermountain Medical Center and Intermountain Clinics
Aug 8, 2022
Inclisiran on Major Adverse Cardiovascular Events in French
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Inclisiran sodium
- +3 more
- (no location specified)
Jul 26, 2023
Cardiovascular Diseases Trial in Ningbo (Frequent and automatic cardiovascular risk assessment, Dynamic risk monitoring, Regular
Not yet recruiting
- Cardiovascular Diseases
- Frequent and automatic cardiovascular risk assessment
- +2 more
-
Ningbo, Zhejiang, ChinaYinzhou District Center for Disease Control and Prevention
Jun 16, 2023
Cardiovascular Diseases Trial in Malmo (Lifestyle tool)
Recruiting
- Cardiovascular Diseases
- Lifestyle tool
-
Malmo, SwedenSkane University Hospital
Apr 26, 2022
Cardiovascular Diseases, Risk Reduction, Primary Prevention Trial (Village doctor-led tailored health management)
Not yet recruiting
- Cardiovascular Diseases
- +2 more
- Village doctor-led tailored health management
- (no location specified)
Dec 7, 2022
Primary Cardiovascular Events Using the Multimarker Approach
Completed
- Cardiovascular Diseases
- +4 more
- measurement of multiple biomarkers
- (no location specified)
Jan 19, 2023
Screening and Secondary Prevention Rheumatic Heart Disease Study
Recruiting
- Rheumatic Heart Disease
-
Karachi, Sindh, PakistanNational Institute of Cardiovascular Diseases (NICVD)
Aug 12, 2023
Left Atrial Appendage Closure as Secondary Prevention of Atrial
Recruiting
- Non-valvular Atrial Fibrillation
- Embolic Stroke
- Transthoracic Echocardiography
-
Jinan, Shandong, China
- +4 more
Dec 15, 2022
Acute Coronary Syndrome Trial in Jakarta (HARKIT I-Care Application)
Recruiting
- Acute Coronary Syndrome
- HARKIT I-Care Application
-
Jakarta, IndonesiaNational Cardiovascular Center Harapan Kita Hospital Indonesia
Nov 27, 2022
Overdose Trial in Baltimore (Peer Education, Narcan Nasal Product)
Recruiting
- Overdose
- Peer Education
- Narcan Nasal Product
-
Baltimore, MarylandLighthouse Studies at Peer Point
Jan 9, 2023
Low-density Lipoprotein Cholesterol Reduction With
Recruiting
- Acute Coronary Syndrome
- Dyslipidemias
-
Banja Luka, Republic Of Srpska, Bosnia and HerzegovinaUniversity Clinical Centre of the Republic of Srpska
Oct 17, 2021
Cardiovascular Diseases, Type 2 Diabetes Trial in Stockholm (Health Dialogue Intervention, Opportunistic Screening)
Not yet recruiting
- Cardiovascular Diseases
- Type 2 Diabetes
- Health Dialogue Intervention
- Opportunistic Screening
-
Stockholm, SwedenCenter for epidemiology and community medicine, Region Stockholm
Sep 27, 2023
Intracranial Hemorrhages Trial in Hamilton (Colchicine Pill, Placebo)
Recruiting
- Intracranial Hemorrhages
- Colchicine Pill
- Placebo
-
Hamilton, Ontario, CanadaHamilton Health Sciences
Aug 12, 2022
Cardiovascular Diseases, Type 2 Diabetes Trial in Malmo (Lifestyle tool)
Recruiting
- Cardiovascular Diseases
- Type 2 Diabetes
- Lifestyle tool
-
Malmo, SwedenSkane University Hospital
Apr 6, 2022
Cardiovascular Disease Trial in Ottawa (PiezoRx medical grade pedometer)
Completed
- Cardiovascular Disease
- PiezoRx medical grade pedometer
-
Ottawa, Ontario, Canada
- +1 more
Feb 8, 2022
Cardiovascular Diseases (CVD) Trial in Basel (Data collection at Baseline, 3 months after baseline (BL), 1-year follow-up,
Recruiting
- Cardiovascular Diseases (CVD)
- Data collection at Baseline, 3 months after baseline (BL), 1-year follow-up, Telephone follow-up and questionnaire 3 years and 5 years after BL
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Outpatient Cardiology
Aug 10, 2022
MACCE According to Time Interval of Taking Medication in Acute
Completed
- Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months
- Esomezol Cap
-
Seoul, Korea, Republic ofHanmi Pharmaceutical Company Limited
Aug 2, 2022
Acute Myocardial Infarction Trial in Milan (Digital empowerment)
Recruiting
- Acute Myocardial Infarction
- Digital empowerment
-
Milan, ItalyCentro Cardiologico Monzino
Mar 22, 2023
Cardiovascular Diseases, Hypertension, Diabetes Trial in New Orleans (Evidence-based interventions recommended by the 2019
Not yet recruiting
- Cardiovascular Diseases
- +3 more
- Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD
-
New Orleans, LouisianaTulane University
Sep 26, 2023
Atherosclerosis Trial in Monaco (18F-Na PET Scan)
Not yet recruiting
- Atherosclerosis
- 18F-Na PET Scan
-
Monaco, MonacoCentre Hospitalier Princesse Grace
Aug 22, 2023
Rheumatic Heart Disease, Rheumatic Heart Disease in Children Trial in Tulsipur (School nurse program)
Recruiting
- Rheumatic Heart Disease
- Rheumatic Heart Disease in Children
- School nurse program
-
Tulsipur, NepalTulsi Secondary Boarding School
Aug 15, 2022
Recurrent Cardiovascular Events in Type 2 Diabetes After PCI
Recruiting
- Diabetes Mellitus
- Percutaneous Coronary Intervention
-
Shanghai, ChinaDepartment of Cardiology,Shanghai Tenth People's Hospital
Nov 22, 2021
Atherosclerotic Plaque Trial (PreventiPlaque App)
Not yet recruiting
- Atherosclerotic Plaque
- PreventiPlaque App
- (no location specified)
Oct 15, 2021